Alexis N. Smith: How Apolipoproteins Influence Platelet Function
Alexis N. Smith, Postdoctoral Fellow at Versiti Inc., shared on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
”Excited to share that my 1st first‑author publication from my postdoc has been published as a JTH Commentary in the Journal of Thrombosis and Haemostasis.
In this commentary, we discussed a recent paper by W. C. Schrottmaier et al., ‘Elevated levels of apolipoprotein C‑III impair platelet function and reduce thrombosis,’ which highlights an unexpected role for apoC‑III beyond its well‑known links to atherosclerosis.
Their work uncovered that apoC‑III can directly inhibit platelet activation and thrombus formation, providing an important foundation for ongoing research into how apolipoproteins influence platelet function.
Many thanks to my postdoctoral mentor, Ze Zheng, for the support and guidance.”
Title: Atherogenic apolipoprotein C-III may not be as bad as we thought
Authors: Alexis N. Smith, Ziyu Zhang, Ze Zheng
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA
-
May 5, 2026, 15:28Soumen Bhattacharyya: Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
-
May 5, 2026, 15:06Wolfgang Miesbach: How Should We Approach GI Angiodysplasia in VWD?